ArticleInternational journal of surgery (London, England)2022

Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies - Correspondence.

Chiranjib Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.